GLP-1 Provider Trust Index 2026: BBB, Trustpilot, FDA Letters — One Table

Why this index exists

No review site cross-references all four trust signals — patient reviews, complaint patterns, FDA enforcement, and litigation — in one place. They quote a Trustpilot score and stop. But in compounded GLP-1, the expensive mistakes live in the other three columns: a 4.6-star provider can carry an FDA warning letter, and a cheap one can carry a pattern-of-complaints alert priced into its prepay. This is the scoreboard.

The trust scoreboard — verified September 2026

How to read each column

Trustpilot measures satisfaction; themes matter more than the score — billing-friction complaints (Zealthy, Mochi) predict your experience better than a 0.5 delta. BBB measures dispute handling; a letter grade alone means little, while a pattern-of-complaints alert (Amble, Mochi) means the same failure repeated. Deep-dive on why the two platforms diverge: Trustpilot vs BBB — which score predicts your experience.Regulatory measures what the company told regulators vs. what it sold — FDA letters (Strut, Zealthy) and NAD referrals (Willow) are about marketing claims, not always product quality. Verdict weighs all three against price.

Three patterns the scoreboard reveals

• Price and trust don't correlate: the cheapest provider (Pomegranate $119) carries an F; a mid-tier one (GobyMeds $169) is cleaner than providers charging twice as much.
• The bad files cluster on billing, not medication: Zealthy, Mochi and Amble all fail on charges and fulfillment — almost no provider fails on the molecule itself.
• Enforcement follows marketing: every FDA letter and NAD referral targets claims — compounded products advertised like approved drugs. Providers that stay conservative in marketing (Enhance.MD, NexLife) stay clean.

The shortlist

Cleanest overall: Enhance.MD (A+ + labs). Best value × clean file: GobyMeds ($169) and NexLife ($119, cancel anytime). Cheapest acceptable: Pomegranate — if you accept thin support for $119 named-pharmacy pricing. Avoid on current evidence: Amble (fulfillment pattern) and Zealthy (heaviest enforcement file in the market).

Pair this with the Price Index (cost axis) and membership-fee map (fee-structure axis) — the three tables together cover every way a provider can cost you money it didn't advertise.

Method

Ratings verified September 2026 from public Trustpilot and BBB pages and published regulatory records. Complaint volumes are snapshot counts, not lifetime totals. A "clean" verdict means no open enforcement, no pattern alert, and no dominant billing-complaint theme — not a guarantee of service quality. Providers with insufficient public data are marked unrated rather than scored.

Affiliate disclosure: This article contains affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. Compounded GLP-1 medications are not FDA-approved as finished products and require a prescription. Ratings verified September 2026 — confirm current files before enrolling.